Jean-Emmanuel KURTZ

PUPH

ORCID – ResearcherID

(+33)

 

 

 

Liste des publications :

 

Rousset-Jablonski, C., Selle, F., Adda-Herzog, E., Planchamp, F., Selleret, L., Pomel, C., … Ray-Coquard, I. (2019). Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers. European Journal of Cancer (Oxford, England: 1990), 116, 35–44. https://doi.org/10.1016/j.ejca.2019.04.018
Malouf, G. G., Beinse, G., Adam, J., Mir, O., Chamseddine, A. N., Terrier, P., … Le Cesne, A. (2019). Brain Metastases and Place of Antiangiogenic Therapies in Alveolar Soft Part Sarcoma: A Retrospective Analysis of the French Sarcoma Group. The Oncologist, 24(7), 980–988. https://doi.org/10.1634/theoncologist.2018-0074
Gantzer, J., Di Marco, A., Fabacher, T., Weingertner, N., Delhorme, J.-B., Brinkert, D., … Kurtz, J.-E. (2019). Conformity to Clinical Practice Guidelines at Initial Management in Adult Soft Tissue and Visceral Tumors since the Implementation of the NetSarc Network in Eastern France. The Oncologist. https://doi.org/10.1634/theoncologist.2018-0751
Joly, F., Ahmed-Lecheheb, D., Kalbacher, E., Heutte, N., Clarisse, B., Grellard, J. M., … Pautier, P. (2019). Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 30(5), 845–852. https://doi.org/10.1093/annonc/mdz074
Herrscher, H., Artzner, T., Severac, F., Faitot, F., Kurtz, J.-E., Janssen-Langenstein, R., … Michard, B. (2019). Intensive care for patients with gastric cancers: outcome and survival prognostic factors. Journal of Gastrointestinal Oncology, 10(2), 292–299. https://doi.org/10.21037/jgo.2018.10.11
Basse, C., Italiano, A., Penel, N., Mir, O., Chemin, C., Toulmonde, M., … Blay, J.-Y. (2019). Sarcomas in patients over 90: natural history and treatment. A nationwide study over 6 years. International Journal of Cancer. https://doi.org/10.1002/ijc.32307
Lange, M., Heutte, N., Noal, S., Rigal, O., Kurtz, J.-E., Lévy, C., … Joly, F. (2019). Cognitive Changes After Adjuvant Treatment in Older Adults with Early-Stage Breast Cancer. The Oncologist, 24(1), 62–68. https://doi.org/10.1634/theoncologist.2017-0570
Denouel, A., Heutte, N., Escudier, B., Kurtz, J.-E., Santos, M. D., Longato, N., … Joly, F. (2018). Sexual Disorders of Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Antiangiogenic Therapies. Clinical Genitourinary Cancer, 16(5), 369-375.e1. https://doi.org/10.1016/j.clgc.2018.05.013
Imperiale, A., Latgé, A., Schaff-Wendling, F., Goichot, B., Kurtz, J.-E., & Malouf, G. G. (2018). Metabolic Response to BRAF-MEK Combination Therapy in Cecal Neuroendocrine Carcinoma With BRAFV600E Mutation and Refractory Lactic Acidosis. Clinical Nuclear Medicine, 43(9), 701–702. https://doi.org/10.1097/RLU.0000000000002231
Bompas, E., Campion, L., Italiano, A., Le Cesne, A., Chevreau, C., Isambert, N., … Blay, J.-Y. (2018). Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study. Cancer Medicine, 7(8), 4023–4035. https://doi.org/10.1002/cam4.1374
Trensz, P., Calvel, L., & Kurtz, J. E. (2018). The hard road to patient-centered care: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer? Annals of Oncology: Official Journal of the European Society for Medical Oncology, 29(7), 1601. https://doi.org/10.1093/annonc/mdy186
Lorcet, M., Lortholary, A., Kurtz, J. E., Berton-Rigaud, D., Fabbro, M., De La Motte Rouge, T., … Joly Lobbedez, F. (2018). [Expectation about maintenance therapy among the GINECO French ovarian cancer cohort from the European NOGGO/ENGOT-ov22 Expression IV survey]. Bulletin Du Cancer, 105(5), 465–474. https://doi.org/10.1016/j.bulcan.2018.01.015
Oskay-Özcelik, G., Alavi, S., Richter, R., Keller, M., Chekerov, R., Cecere, S. C., … Sehouli, J. (2018). Expression III: patients’ expectations and preferences regarding physician-patient relationship and clinical management-results of the international NOGGO/ENGOT-ov4-GCIG study in 1830 ovarian cancer patients from European countries. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 29(4), 910–916. https://doi.org/10.1093/annonc/mdy037
Rousset-Jablonski, C., Selle, F., Adda-Herzog, E., Planchamp, F., Selleret, L., Pomel, C., … Ray-Coquard, I. (2018). [Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer]. Bulletin Du Cancer, 105(3), 299–314. https://doi.org/10.1016/j.bulcan.2017.10.032
Walter, T., Malka, D., Hentic, O., Lombard-Bohas, C., Le Malicot, K., Smith, D., … Lepage, C. (2018). Evaluating bevacizumab in combination with FOLFIRI after the failure of platinum-etoposide regimen in patients with advanced poorly differentiated neuroendocrine carcinoma: The PRODIGE 41-BEVANEC randomized phase II study. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 50(2), 195–198. https://doi.org/10.1016/j.dld.2017.11.020